Patent Specialist

Longevity InTime; New York (NY); Remote; USD 120,000 - 180,000; Part time

Benefits offered by this job

Remote work

Flexible location

Job summary

Longevity InTime LLC seeks a USPTO-registered patent attorney or agent for an AI and computational biology portfolio. This remote contract engagement supports US and PCT filings with flexible location as long as USPTO registration is current.

The role focuses on Section 101 considerations under Alice, grouping strategies, and potential PTAB appeals. The work involves managing ongoing provisional filings, coordinating with home-country counsel, and delivering a robust prosecution plan, including

Qualifications

• Prosecution experience in software, AI or computational biology.
• Experience handling Section 101 rejections, incl. Federal Circuit trends.
• PCT filings for non-US applicants and coordination with home-country counsel.
• Experience with PTAB ex parte appeals or a clear resourcing plan.

Responsibilities

• Develop filing strategy for grouping and unity of invention and offices.
• Manage US and PCT prosecution deadlines and responses.
• Coordinate with home-country counsel and local practitioners.
• Lead PTAB ex parte appeal processes or plan for resourcing them.
• Provide candid technical and strategy feedback to founders when grouping plans are challenged.

Skills

Prosecution experience

Section 101 handling

PCT filings

PTAB appeals planning

Regulatory communication

Education

USPTO registration

Job description

Hiring: USPTO-registered patent attorney or agent for an AI and computational biology portfolio (contract, remote)

Longevity InTime LLC builds autonomous AI systems for longevity research. We need a USPTO-registered patent attorney or agent for our US and PCT work. This is a contract engagement and fully remote. Location is flexible as long as you're registered with the USPTO.

The applicant on our filings is domiciled outside the US, so since July 20, 2026, our USPTO papers have to be signed by a registered practitioner.

What the work involves

PCT program. We have 29 US provisional applications filed between March and May 2026. Twenty-seven are standalone and two were drafted as the basis for consolidated (mega) PCT applications. The first PCT deadline is in March 2027. We need a filing strategy covering grouping and unity of invention, the choice of applicant and receiving office, Section 101 exposure and a phased budget. Then we need it carried out.

US prosecution. A pending US application with a 2020 priority date is under a Section 101 rejection, and the next deadline is about two months away. PTAB ex parte appeal experience helps here.

The subject matter is multi-agent AI architecture, closed-loop research systems, computational drug discovery and computational biology. These are software and systems claims in a life sciences setting, so Section 101 under Alice is central to the job.

What we're looking for

• - Prosecution experience in software, AI or computational biology
• - A track record on Section 101 rejections, including recent Federal Circuit treatment of machine learning claims
• - PCT filings for non-US applicants, including applicant structure, receiving office choice and coordination with home-country counsel
• - PTAB ex parte appeals, or a clear plan for resourcing one
• - Willingness to tell a founder his grouping plan is wrong